HedgeChatter

  • Home /
  • Tag Archives

AMGN

Phase 3 DECISION Trial of NEXAVAR (sorafenib) in Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory to Radioactive Iodine Published in The Lancet

[PR Newswire] – WHIPPANY, N.J. and THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., April 23, 2014 /PRNewswire/ — Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: … moreView todays social media effects on AMGNView the latest stocks trending across Twitter. Click to view dashboardSee who Amgen is hiring next, click here to view […]

April 23, 2014 Bystocknews , Comments Off on Phase 3 DECISION Trial of NEXAVAR (sorafenib) in Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory to Radioactive Iodine Published in The Lancet read more

3 Reasons Celgene Will Bounce Back This Year

moreView todays social media effects on AMGNView the latest stocks trending across Twitter. Click to view dashboardSee who Amgen is hiring next, click here to view […]

April 23, 2014 Bystocknews , Comments Off on 3 Reasons Celgene Will Bounce Back This Year read more

Amgen’s CEO Discusses Q1 2014 Results – Earnings Call Transcript

[Seeking Alpha] – I’d like to welcome you to our conference call to review our operating performance for the first quarter of this year. Our performance gives us confidence that we are on track to deliver our full year guidance. Bob will provide a brief moreView todays social media effects on AMGNView the latest stocks trending across Twitter. Click […]

April 23, 2014 Bystocknews , Comments Off on Amgen’s CEO Discusses Q1 2014 Results – Earnings Call Transcript read more

Amgen Posts Lower-Than-Expected Earnings

moreView todays social media effects on AMGNView the latest stocks trending across Twitter. Click to view dashboardSee who Amgen is hiring next, click here to view […]

April 23, 2014 Bystocknews , Comments Off on Amgen Posts Lower-Than-Expected Earnings read more

8:48 am Amgen disclosed on April 7, 2014, Thomas Dittrich informed AMGN that, effective August 2, 2014, he will resign as its Vice President, Finance and Chief Accounting Officer to pursue an opportunity to serve as the CFO of a Swiss-based

moreView todays social media effects on AMGNView the latest stocks trending across Twitter. Click to view dashboardSee who Amgen is hiring next, click here to view […]

April 9, 2014 Bystocknews , Comments Off on 8:48 am Amgen disclosed on April 7, 2014, Thomas Dittrich informed AMGN that, effective August 2, 2014, he will resign as its Vice President, Finance and Chief Accounting Officer to pursue an opportunity to serve as the CFO of a Swiss-based read more